2026-05-27T05:35:15Zhttps://riuma.uma.es/rest/oai/request

oai:riuma.uma.es:10630/257222026-02-03T12:19:36Zcom_10630_2254col_10630_37959

Burgos-Molina, Antonio Manuel Alamilla Presuel, Juan Carlos González Vidal, Alejandro Ruiz-Gómez, Miguel José 2023-01-12T10:05:29Z 2023-01-12T10:05:29Z 2022 https://hdl.handle.net/10630/25722 Cells need energy to survive, therefore, they increase the different pathways available to obtain it. This suggests that the cell, due to the cytotoxicity of bleomycin, increases the routes to obtain energy. For this reason, GPM1 could be a good candidate as bleomycin chemo-resistance biomarker. Knowing of the homologous gene in humans facilitates more studies of the expression of this protein in tumors. eng http://creativecommons.org/licenses/by-nc-nd/4.0/ open access Attribution-NonCommercial-NoDerivatives 4.0 Internacional Metabolismo - Congresos Metabolism is altered in the process of drug resistance acquisition conference output